SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-23-021744
Filing Date
2023-02-14
Accepted
2023-02-14 16:35:27
Documents
1
Group Members
DAK CAPITAL INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm236698d1_sc13da.htm SC 13D/A 73371
  Complete submission text file 0001104659-23-021744.txt   74781
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Subject) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86661 | Film No.: 23630400
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1702 BELL TOWER, 10104-103 AVENUE EDMONTON Z4 T5J 0H8
Business Address
KATZ DARYL (Filed by) CIK: 0001625637 (see all company filings)

Type: SC 13D/A